EN DE

PT Era Mandiri Cemerlang Tbk (IKAN) Fair Value & Analysis

Consumer Defensive · ID · Market cap 70.8B IDR

PE PT Era Mandiri Cemerlang Tbk IKAN · JK
Price85.00 IDR
Fair Value14.03 IDR
Upside-83.5%
Quality61/100
Watch PT Era Mandiri Cemerlang Tbk for free, get notified when fair value or trend changes. Watch for free
Healthy Growth
Loss-making · -0.4% net margin
Low debt · generates free cash flow
Trails peers (3/10)
Narrow moat 23/100
Evidence: High Range 8.52 IDR – 17.54 IDR Share as image

Fair value as of: Jul 18, 2026

From 23 valuation models · updated 23 days ago

Share price +9.0% over the past month.

A solid business, but screening 83% overvalued on our models.

What matters now

  • The price sits above even our optimistic bull case (17.54 IDR). The favourable scenario is already priced in.
  • Solid but not exceptional quality (61/100) and above fair value, neither a clear bargain nor a standout compounder.
  • A fairly wide model range (8.52 IDR to 17.54 IDR) leaves room in how you read the outcome.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

242.00 IDR 13.00 IDR Fair Value 14.03 IDR Feb 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 18, 2026.

How to read this chart

60‑month range 13.00 IDR – 242.00 IDR · fair‑value band 8.52 IDR – 17.54 IDR · the 85.00 IDR price screens above the 14.03 IDR fair value. Dashed = 300-day average. As of Jul 18, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

PT Era Mandiri Cemerlang Tbk (IKAN) currently trades at 85.00 IDR, while our model-based Fair Value estimate is 14.03 IDR, implying the stock looks roughly 83.5% overvalued today. The Quality Score stands at 61/100 (solid quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, PT Era Mandiri Cemerlang Tbk generated revenue of 119B IDR at a net margin of -0.4%. Revenue declined 12.1% year over year. It earns a return on equity of -0.6%. Net debt stands at 41.2B IDR. Fundamentals as of Jul 18, 2026

Our scenario range runs from 8.52 IDR (bear case) to 17.54 IDR (bull case); at 85.00 IDR, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 55% below its 52-week high and 49% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at 102% fair-value upside, at -83%, IKAN screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF 117.37 IDR 164.83 IDR 230.28 IDR 80
Rev-Margin DCF 65.20 IDR 87.96 IDR 113.41 IDR 74
ROIC Compounder 37.58 IDR 43.21 IDR 48.15 IDR 72
All 23 models by family
DCF Models
FCF DCF 114.40 IDR 166.00 IDR 240.61 IDR 38
Owner Earnings 49.65 IDR 71.06 IDR 102.02 IDR 31
5Y Revenue Exit 65.20 IDR 86.15 IDR 110.95 IDR 39
5Y EBITDA Exit 89.19 IDR 129.26 IDR 173.76 IDR 41
5Y P/E Exit 49.48 IDR 57.90 IDR 65.59 IDR 38
10Y Revenue Exit 81.46 IDR 103.85 IDR 130.18 IDR 36
10Y EBITDA Exit 97.55 IDR 133.15 IDR 176.39 IDR 37
10Y P/E Exit 72.64 IDR 84.65 IDR 96.82 IDR 35
Earnings-Based
Graham-Dodd 4.54 IDR 11.37 IDR 14.75 IDR 54
PEG = 1.0 2.08 IDR 2.97 IDR 3.87 IDR 46
EPV 37.58 IDR 43.21 IDR 48.15 IDR 59
Multiples
P/E Multiple 10.52 IDR 14.03 IDR 17.54 IDR 63
P/S Multiple 8.52 IDR 11.36 IDR 14.20 IDR 58
P/B Multiple 8.52 IDR 11.36 IDR 14.20 IDR 55
EV/EBIT 54.07 IDR 70.85 IDR 87.62 IDR 53
EV/EBITDA 84.90 IDR 111.95 IDR 139.00 IDR 54
EV/Revenue 39.66 IDR 55.06 IDR 70.45 IDR 43
Asset-Based
NCAV (Graham) 44.99 IDR 60.29 IDR 89.99 IDR 50
Growth DCF
Growth DCF 117.37 IDR 164.83 IDR 230.28 IDR 80
Rev-Margin DCF 65.20 IDR 87.96 IDR 113.41 IDR 74
Economic Profit
Residual Income 60.96 IDR 56.18 IDR 40.19 IDR 61
ROIC Compounder 37.58 IDR 43.21 IDR 48.15 IDR 72
Growth Earnings
Growth-Adj P/E 8.11 IDR 11.59 IDR 15.07 IDR 68

Widest divergence: Growth DCF (87.96 IDR) versus Earnings-Based (11.37 IDR). Highest evidence: Growth DCF (80).

Notify me when IKAN reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) 119B IDR
Revenue growth (YoY) -12.1%
Net margin -0.4%
Return on equity -0.6%
Free cash flow 8.5B IDR FY2025
P/E ratio 43.4
More key figures
Operating margin 0.6%
EPS (TTM) 1.96 IDR
EPS growth (YoY) -87.4%
Net debt 41.2B IDR FY2025

Figures from reported company fundamentals · as of Jul 18, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 61/100

Of which business quality 61 · Market factors (momentum, volatility) 23

Profitability 30
Margins and returns on capital today
Quality Growth 54
Are margins and returns improving?
Cashflow 68
Earnings quality: real cash, not paper profit
Fin. Strength 56
Balance sheet, leverage, solvency risk
Investment 98
Disciplined investing over empire-building
Low Volatility 50
Calm price path (market factor)
Momentum 12
Price trend over the last 3–12 months (market factor)
52W Momentum 10
Distance to the 52-week high (market factor)
Net Issuance 82
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

PT Era Mandiri Cemerlang Tbk produces and supplies seafood products in Indonesia and internationally. The company offers yellowfin tuna, bigeye tuna, oilfish, swordfish, black pomfret, Spanish mackerel, shark, red snapper, bullet tuna, skipjack tuna, wahoo, goldband snapper, leather jacket, emperor, parrotfish, mahi-mahi, grouper, milkfish, and other fish …

Full company description

PT Era Mandiri Cemerlang Tbk produces and supplies seafood products in Indonesia and internationally. The company offers yellowfin tuna, bigeye tuna, oilfish, swordfish, black pomfret, Spanish mackerel, shark, red snapper, bullet tuna, skipjack tuna, wahoo, goldband snapper, leather jacket, emperor, parrotfish, mahi-mahi, grouper, milkfish, and other fish products; squid products; and octopus products. It exports its products to the United States, Mexico, Ecuador, Germany, the Netherlands, Poland, Portugal, Hong Kong, China, India, the Philippines, and various Middle Eastern countries. PT Era Mandiri Cemerlang Tbk was founded in 2000 and is headquartered in Jakarta Utara, Indonesia.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

PT Era Mandiri Cemerlang Tbk reported revenue of 123B IDR in FY2025 versus 111B IDR in FY2021, a compound +2.4%/yr. Reported net income was 557M IDR in FY2025, compounding −23.2%/yr from FY2021.

Growth Quality 70/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Latest Revenue (FY 2025)
123B IDR
Latest YoY
+5.0%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+2.6%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+7.7%
Avg. growth/yr (8Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+7.1%
Revenue +2.4%/yr
FY21 111B IDR
FY22 113B IDR
FY23 144B IDR
FY24 117B IDR
FY25 123B IDR
Net income −23.2%/yr
FY21 1.6B IDR
FY22 2.0B IDR
FY23 934M IDR
FY24 432M IDR
FY25 557M IDR

IKAN screens 83% overvalued. Compare with Muyuan Foods Group →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "PT Era Mandiri Cemerlang Tbk Fair Value". https://www.fairvalue-calculator.com/stock/IKAN

Peer Group

Farm Products · 288 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 61 · Above median
Fair Value upside −84% · Bottom 25%
Return on assets 1% · Below median
Net margin (TTM) -0% · Below median
Operating margin (TTM) 1% · Below median
Revenue growth -12% · Bottom 25%
Debt / equity 0.02× · Lower than 75% of peers

Valuation Multiples vs Farm Products median · lower = cheaper

P/E (TTM) 43.4× · Pricier than 75% of peers
P/FCF 0.0× · Cheaper than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 25
FUTURE 0 · sector 20
PAST 0 · sector 17
HEALTH 99 · sector 94
DIVIDEND 0 · sector 38

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Farm Products stocks, each showing price versus our Fair Value estimate (as of Jul 18, 2026).

Stock Price Fair Value vs Fair Value
Muyuan Foods Group 002714 ¥40.90 ¥48.19 +18%
Wens Foodstuff Group 300498 ¥14.51 ¥12.08 -17%
Mowi ASA MOWI kr 188.40 kr 262.59 +39%
PT Charoen Pokphand Indonesia Tbk, CPIN 3,120 IDR 7,076 IDR +127%
Charoen Pokphand Foods Public Company CPF 22.00 THB 55.71 THB +153%
PT Triputra Agro Persada Tbk TAPG 1,540 IDR 3,105 IDR +102%
PT FAP Agri Tbk FAPA 7,300 IDR 7,463 IDR +2%
PT Japfa Comfeed Indonesia Tbk JPFA 2,070 IDR 7,231 IDR +249%
Thaifoods Group TFGR 10.60 THB 23.53 THB +122%
PT Jhonlin Agro Raya Tbk JARR 1,845 IDR 610.80 IDR -67%

Compare PT Era Mandiri Cemerlang Tbk with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is PT Era Mandiri Cemerlang Tbk (IKAN) overvalued or undervalued?
As of Jul 18, 2026, our model estimates a fair value of 14.03 IDR versus a price of 85.00 IDR, about −83% (overvalued).
What is the fair value of IKAN?
Our model-based fair value for PT Era Mandiri Cemerlang Tbk is 14.03 IDR (as of Jul 18, 2026), built from audited fundamentals. The current price is 85.00 IDR.
What is the quality score of IKAN?
PT Era Mandiri Cemerlang Tbk has a Quality Score of 61/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of PT Era Mandiri Cemerlang Tbk (IKAN)?
PT Era Mandiri Cemerlang Tbk reported trailing-twelve-month revenue of about 119B IDR (latest available figure, as of Jul 18, 2026).
What is the net profit margin of IKAN?
The net profit margin of PT Era Mandiri Cemerlang Tbk is about -0.4%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track PT Era Mandiri Cemerlang Tbk and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.